Top entities: Regencell Bioscience Holdings, Bronstein, Gewirtz & Grossman, LLC, Peretz Bronstein, Nathan Miller.

What category does this event fall under?

Regulatory — classified as class action lawsuit.

What is the sentiment of coverage?

Aggregate sentiment score: -50 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This is an active story, last updated May 28, 2026. Coverage continues to evolve.

Regulatory class action lawsuit

Regencell Bioscience Holdings faces class action

Q: When did this event occur?

First reported May 19, 2026; last updated May 28, 2026.

Q: What is the market impact?

Direct. The class action lawsuit against Regencell Bioscience Holdings is likely to negatively impact its stock price due to allegations of market manipulation and misleading statements.

Analysis based on 11 articles · First reported May 19, 2026 · Last updated May 28, 2026

Sentiment

-50

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The class action lawsuit against Regencell Bioscience Holdings is likely to negatively impact its stock price due to allegations of market manipulation and misleading statements. Investors in Regencell Bioscience Holdings face significant financial risk and potential losses, while Bronstein, Gewirtz & Grossman, LLC stands to gain if the lawsuit is successful.

Biotechnology Legal Services

Event Summary

A class action lawsuit has been filed against Regencell Bioscience Holdings by Bronstein, Gewirtz & Grossman, LLC, on behalf of investors who purchased Regencell Bioscience Holdings securities between October 28, 2024, and October 31, 2025. The complaint alleges that Regencell Bioscience Holdings made materially false and misleading statements regarding its business, operations, and compliance policies, specifically that it was vulnerable to market manipulation, which exposed investors to significant financial risk. This situation subjects Regencell Bioscience Holdings to heightened regulatory scrutiny, enforcement action, and potential legal, monetary, and reputational harm. Peretz Bronstein and Nathan Miller are key contacts for investors.

Key Actions

100 Bronstein, Gewirtz & Grossman, LLC filed class action lawsuit Regencell Bioscience Holdings

Entities Involved

stock

Regencell Bioscience Holdings

Regencell Bioscience Holdings is the defendant in a class action lawsuit alleging violations of federal securities laws, which could lead to significant legal, monetary, and reputational harm.

Importance 100 Sentiment -70

priv

Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman, LLC is the law firm that filed the class action lawsuit against Regencell Bioscience Holdings, representing investors seeking to recover damages.

Importance 90 Sentiment 60

per

Peretz Bronstein

Peretz Bronstein is the Founding Partner of Bronstein, Gewirtz & Grossman, LLC, and is involved in the class action lawsuit against Regencell Bioscience Holdings.

Importance 70 Sentiment 50

per

Nathan Miller

Nathan Miller is the Client Relations Manager for Bronstein, Gewirtz & Grossman, LLC, and is a contact for investors regarding the Regencell Bioscience Holdings class action lawsuit.

Importance 60 Sentiment 40

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard